Computerized Visual Acuity Test Effective for Children

This article originally appeared here.
Share this content:
Computerized Visual Acuity Test Effective for Children
Computerized Visual Acuity Test Effective for Children

MONDAY, May 4, 2015 (HealthDay News) -- A computerized visual acuity-based screening program that employs a rapid, age-specific standardized algorithm is effective and practical for screening 3- to 7-year-old children, according to a study published in the April issue of the Journal of the American Association for Pediatric Ophthalmology and Strabismus.

Tomohiko Yamada, O.D., from the Mayo Clinic in Rochester, Minn., and colleagues developed and validated the Jaeb Visual Acuity Screener (JVAS) for vision screening in the medical home. One hundred seventy-five children aged 3 to younger than 8 years were screened with the JVAS and then underwent a complete eye examination (gold standard). Two large single surround optotypes were presented by the JVAS and then five optotypes were presented at a predetermined, age-specific normal threshold. The sensitivity and specificity of the JVAS for detecting reduced visual acuity, amblyopia, and amblyopia risk factors was assessed.

The researchers found that there was high screening testability for the JVAS (100 percent). Sensitivity and specificity of the JVAS ranged from 88 to 91 percent and from 73 to 86 percent, respectively. Positive predictive values ranged from 66 to 79 percent, and negative predictive values varied from 92 to 93 percent.

"The new JVAS provides an effective and practical method for screening 3- to 7-year-olds using any Windows-based computer," the authors write. "Providing the JVAS free-of-charge to pediatricians and school systems would standardize currently fragmented visual acuity-based screening practices."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Ground Beef Recalled After E. Coli Outbreak

Ground Beef Recalled After <i>E. Coli</i> Outbreak

Beef was produced and packaged at Cargill Meat Solutions in Fort Morgan, Colo.

Prevalence of Alzheimer's, Related Dementia Set to Double

Prevalence of Alzheimer's, Related Dementia Set to Double

Alzheimer's disease and related dementias burden is expected to increase to 3.3 percent in 2060

Long-Term Outcomes of Breast Implants Explored

Long-Term Outcomes of Breast Implants Explored

Higher rates of Sjogren syndrome, scleroderma, RA, stillbirth, melanoma for silicone implants

is free, fast, and customized just for you!




Already a member?

Sign In Now »